Max Jaderberg
Overview
Max Jaderberg is a machine learning researcher and president of Isomorphic LabsIsomorphic LabsIsomorphic Labs is an Alphabet company that uses artificial intelligence to design and develop medicines. It was founded by Demis Hassabis, who is its CEO.Open the full entry. After studying computer vision at Oxford and co-founding the image recognition company Vision Factory, he led an open-ended learning research team at Google DeepMindGoogle DeepMindGoogle DeepMind is Google’s artificial intelligence research organization, formed in April 2023 by merging DeepMind, which Google acquired in 2014, with the Brain team from Google Research, and led by CEO Demis Hassabis. It developed AlphaGo, AlphaFold, and the Gemini family of models, and Hassabis and John Jumper received the 2024 Nobel Prize in Chemistry for AlphaFold’s protein structure prediction work.Open the full entry. He joined Isomorphic Labs at its founding in 2021 and served as chief AI officer, overseeing research that included AlphaFold 3.[1][2]
Contents9 sections
Key facts
Education: Engineering science and computer vision at Oxford
Jaderberg studied engineering science as an undergraduate at Oxford, then pursued a doctorate in its Visual Geometry Group, studying how neural networks could read text in images. His professional profile dates his graduate research to 2012–2015 and names Andrew Zisserman and Andrea Vedaldi as his supervisors.[2][3]
His professional profile records the Michael Zola Prize at Keble College for his performance in preliminary examinations in 2009. In 2012 he received the college’s Franklin Prize for Engineering Science and Oxford’s Head of Department Prize for his examination results.[3]
Career: From image recognition to learning in games
Jaderberg co-founded and ran Vision Factory, which developed image recognition technology using deep learning. GoogleGoogleGoogle is an American technology company founded by Larry Page and Sergey Brin and incorporated in 1998. It became an Alphabet subsidiary in 2015. Its businesses include internet search, advertising, software platforms, cloud computing, and artificial intelligence.Open the full entry acquired the company in 2014 and brought it into DeepMind. His publications from this period include work with colleagues on recognizing text in natural scenes and a 2015 paper on spatial transformer networks.[2][4]
Career: Joining the founding team at Isomorphic Labs
Isomorphic Labs was founded in 2021. As a member of the founding team, Jaderberg set its AI research direction and became chief AI officer. He helped lead development of its drug discovery platform and AlphaFold 3. As president, he leads the company alongside Demis HassabisDemis HassabisDemis Hassabis is a British artificial intelligence researcher and entrepreneur, co-founder of DeepMind and its CEO and that of Google DeepMind from 2010 to 2026, and since then Chair of Google DeepMind, Chief Scientist of Alphabet and CEO of Isomorphic Labs; a former chess prodigy and game designer, he shared the 2024 Nobel Prize in Chemistry with John Jumper for AlphaFold’s protein structure prediction, and has appeared twice on the Lex Fridman Podcast.Open the full entry, working to make the platform usable across successive drug programs and to move candidates from the laboratory toward the clinic.[1][2]
Interview: Drug discovery and clinical research
In a November 2026 interview with Elad GilElad GilElad Gil is an entrepreneur, investor and author of High Growth Handbook. He co-founded Mixer Labs and Color, worked at Google and Twitter, runs the multistage investment firm Gil & Co, and co-hosts the No Priors podcast with Sarah Guo.Open the full entry on No PriorsNo PriorsNo Priors is an AI interview podcast and media brand founded and hosted by investors Sarah Guo and Elad Gil, with episodes beginning in February 2023. It covers research, startups, infrastructure and business applications through guest interviews, host discussions and retrospectives distributed on audio platforms and YouTube.Open the full entry, Jaderberg recalled how early AlphaFold results shaped the founding team’s thinking and explained why he wanted more early drug discovery work to take place on computers. He discussed the distinction between predictions and clinical outcomes, the choice of endpoints, when to pursue partnerships, and how development timelines affect the risks a company can take.[5]
Advice Shared on No Priors
He cautioned researchers that a hypothesis produced by a model still needs real-world validation before anyone can judge its value for people. (26:04)[5]
When discussing ways to speed development, he urged teams to keep patient safety in view throughout. (32:30)[5]
Related Organizations, Websites and Public Accounts
Isomorphic Labs: President. Official website: https://www.isomorphiclabs.com/ (opens in a new window).[1]
His [personal website](https://www.maxjaderberg.com/ (opens in a new window)) lists his publications and links to [X (@maxjaderberg)](https://x.com/maxjaderberg (opens in a new window)), [LinkedInLinkedInLinkedIn is a social networking platform for professionals. It was founded in 2002 by Reid Hoffman and others, launched in 2003, and listed on the New York Stock Exchange in 2011; after Microsoft acquired it for approximately $26.2 billion in 2016, it became a wholly owned Microsoft subsidiary. Its revenue comes from membership subscriptions, advertising, and recruitment solutions.Open the full entry (maxjaderberg)](https://www.linkedin.com/in/maxjaderberg/ (opens in a new window)), and his [Google Scholar profile](https://scholar.google.com/citations?user=JeZoMicAAAAJ (opens in a new window)).[1][4]
November 12, 2026Interview with No Priors
As a practical example, he said the company was expanding its clinical development team to prepare for the transition from research to work involving patients.[5]
Sources5 sources
- Max Jaderberg, PhD, President (opens in a new window)isomorphiclabs.com↑
- Max Jaderberg, keynote speaker, 2026 Machine Learning in Drug Discovery Symposium (opens in a new window)broadinstitute.org↑
- Max Jaderberg — Isomorphic Labs (opens in a new window)uk.linkedin.com↑
- Max Jaderberg (opens in a new window)maxjaderberg.com↑
- Powering AI-Driven Drug Discovery with President of Isomorphic Labs Max Jaderberg (opens in a new window)youtube.com↑